Logistics shortcomings have become a constraint on the development of pharmaceutical business allocation business
As my country’s pharmaceutical business gradually transforms into an open economic format, the past model of drug distribution in a small area has become Not common. In Jiangsu, Hubei, Shandong and other provinces, many pharmaceutical commercial companies often use the network of social third-party logistics companies to ship large quantities of medicines to all parts of the country. The author believes that this pharmaceutical commercial sales model, in which drugs are imported and exported in batches and allocated from different places, will become popular in the domestic market in the future.
However, as the pharmaceutical commercial allocation business expands, third-party logistics has in turn restricted the development of the pharmaceutical allocation business. As we all know, in addition to the circulation characteristics of ordinary goods, pharmaceutical logistics also has special requirements for logistics links due to the particularity of drug storage. In addition, the characteristic of pharmaceutical allocation is the off-site batch distribution of high-value drugs, and the high value of goods also imposes The service capabilities and security of third-party logistics have put forward higher requirements. However, the current overall service level of my country's third-party logistics cannot meet the development needs of pharmaceutical commercial allocation business.
Service quality needs to be improved urgently
Our country’s professional third-party pharmaceutical logistics companies only began to operate in practice in 2004, and the qualification accreditation of pharmaceutical logistics companies only began in 2006 in some developed countries in East China. Due to the late start, there is currently no professional third-party pharmaceutical logistics provider with a logistics network covering the entire country. Therefore, most of the goods allocated and sold by pharmaceutical commercial companies can only be realized through those popular freight companies in society that mainly cater to the circulation of general goods. However, due to different industry characteristics, ordinary freight companies cannot meet the needs of pharmaceutical companies, and service quality needs to be improved urgently. For example, the medicines allocated by the pharmaceutical business are often products with obvious price differences between the purchasing and selling parties, so the timeliness of distribution is very high. However, the current average time for domestic third-party logistics companies to allocate medicines is 3 to 5 days; and those that can achieve the circulation of medicines across the country (except for remote provinces and regions such as Xinjiang, Inner Mongolia, Gansu, Heilongjiang, and Tibet) within two days For logistics companies, transportation prices are terrifyingly high. In addition, for medicines that require refrigeration, if they are to be delivered to county-level markets, it is generally difficult for social logistics companies to achieve low-temperature distribution of the medicines throughout the process. It can be seen that the logistics service level of third-party logistics companies in the society for pharmaceutical business is still far from the needs of enterprises.
Difficult to solve the problem of payment recovery
Most of the single transfer business in medical transfer is of high value, especially the cross-provincial transfer, and the value of some single business even exceeds one million Yuan. Such large-amount transactions are usually delivered upon payment, but there are still some allocation businesses of less than tens of thousands of yuan that require delivery. The recovery of these payments is a major problem in the allocation business of commercial companies.
Generally speaking, pharmaceutical commercial companies will not easily let third-party logistics companies collect payment on their behalf. This is because the phenomenon of "evaporation" of payment in my country's highway logistics and distribution industry is relatively serious: at the beginning of this year, the boss of the "Integrity Freight Department" of the Donghuan Wholesale Market in Yinchuan City, Ningxia took away more than 370,000 yuan in payment from dozens of merchants in the market. ; Coincidentally, in Shandong Province, Guowei Logistics Company, headquartered in Linyi, disappeared after taking away millions of yuan in customer payments.
The underlying reason for the occurrence of such cases is that the threshold for starting a freight company in my country is too low and lacks sufficient restrictive conditions. It is reported that under normal circumstances, as long as the name of the applicant for the freight department does not overlap with the freight department already on the market, it can be approved. There are no requirements for the applicant's funds, self-owned vehicles and other hardware standards that can prove its strength. high. Therefore, once the freight department or the so-called freight company itself encounters economic risks, it will be difficult to guarantee the interests of the entrusted merchants. Under such circumstances, pharmaceutical commercial enterprises naturally do not dare to hand over the "payment collection" business to logistics companies easily, which in turn restricts the further expansion of the allocation business.
To develop within regulations
It should be said that the expansion of the pharmaceutical business requires the support of third-party logistics; and the expansion of the third-party logistics business requires continuous expansion of services field. Therefore, solving the problem that the social third-party logistics service level cannot meet the needs of pharmaceutical commercial allocation requires the joint efforts of all parties.
The author believes that, on the one hand, the government should formulate more reasonable and complete policies to regulate the market. For example, we should appropriately raise the registration threshold for third-party logistics companies, increase the cost of corporate dishonesty, and guide powerful logistics companies to become bigger and stronger. Logistics industry associations can implement special service field access systems, payment collection access systems, etc. in the industry, stipulating that only logistics companies that reach a certain scale and integrity level can enter the pharmaceutical industry and carry out payment collection business. It needs to be emphasized that industry associations should collect part of the accident deposit and integrity deposit.
On the other hand, relevant government departments should also actively explore and promote a professional pharmaceutical logistics enterprise access system, and encourage excellent logistics companies and pharmaceutical commercial companies to obtain professional pharmaceutical logistics qualifications, so that different industries can achieve Liaison with regulations.
As a pharmaceutical commercial company, we also need to strengthen our awareness of standardized operations. The author has seen that many third-party logistics service providers of pharmaceutical commercial companies are individual freight forwarders or freight departments of individual merchants. The two parties have not even signed a freight contract, and only rely on the personal relationship between the transportation director and the other company to conduct business. In this way, if an accident occurs, there is basically no possibility of compensation. Therefore, pharmaceutical commercial companies should also pay attention to standardized operations, choose reliable logistics companies, and minimize market risks. Only in this way can the allocation and consignment business be bigger.